The Role of ANRIL in Atherosclerosis.
Iman Razeghian JahromiAli Karimi AkhormehMohammad Javad ZibaeenezhadPublished in: Disease markers (2022)
There is a huge number of noncoding RNA (ncRNA) transcripts in the cell with important roles in modulation of different mechanisms. ANRIL is a long ncRNA with 3.8 kb length that is transcribed in the opposite direction of the INK4/ARF locus in chromosome 9p21. It was shown that polymorphisms within this locus are associated with vascular disorders, notably coronary artery disease (CAD), which is considered as a risk factor for life-threatening events like myocardial infarction and stroke. ANRIL is subjected to a variety of splicing patterns producing multiple isoforms. Linear isoforms could be further transformed into circular ones by back-splicing. ANRIL regulates genes in atherogenic network in a positive or negative manner. This regulation is implemented both locally and remotely. While CAD is known as a proliferative disorder and cell proliferation plays a crucial role in the progression of atherosclerosis, the functions of ANRIL and CAD development are intertwined remarkably. This makes ANRIL a suitable target for diagnostic, prognostic, and even therapeutic aims. In this review, we tried to present a comprehensive appraisal on different aspects of ANRIL including its location, structure, isoforms, expression, and functions. In each step, the contribution of ANRIL to atherosclerosis is discussed.
Keyphrases
- coronary artery disease
- cell proliferation
- cardiovascular disease
- heart failure
- stem cells
- cardiovascular events
- single cell
- percutaneous coronary intervention
- cell therapy
- gene expression
- genome wide
- long non coding rna
- mesenchymal stem cells
- binding protein
- bone marrow
- acute coronary syndrome
- blood brain barrier
- neural network
- pi k akt
- brain injury
- ejection fraction